stars 1 stars 2 stars 3

Apheris delivers enterprise-grade AI applications for drug discovery, designed for pharma companies to run and customize securely within their own IT environments. By keeping all data local, organizations maintain full sovereignty over IP-sensitive assets. These local deployments also serve as the foundation for Apheris-hosted federated data networks, where pharma companies collaboratively train and benchmark models on proprietary datasets to unlock more robust and generalizable models for drug discovery.

Apheris Questions

The Apheris annual revenue was $7.4 million in 2026.

Robin Roehm is the CEO and Co-Founder of Apheris.

42 people are employed at Apheris.

Apheris is based in Berlin, Berlin.

Top Apheris Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users